Bharat Biotech Current Affairs, GK & News
IndRa: Cost of vaccinating India’s population above 18 years 0.36% of GDP
The India Ratings and Research (Ind-Ra) recently said the estimated cost to vaccinate all the Indians of age 18 years will be Rs 67,193 crores. This is 0.36% of the GDP of the country. Key Findings The GoI recently announced the Liberalised and Accelerated Phase 3 strategy of COVID-19 vaccine. According to the new strategy, ..
Month: Current Affairs - April, 2021
Category: Reports & Indexes Current Affairs
Topics: Bharat Biotech • COVAXIN • COVID-19 vaccine • Covishield • Ind-Ra • Serum Institute of India
COVAXIN: Transfer of Technology from Bharat Biotech to Haffkine
The Government of India recently approved the transfer of technology from Bharat Biotech to Hafkine Institute. COVAXIN COVAXIN is one of the two drugs that is currently administered in India. It is manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research. The COVAXIN is produced by making the Corona Virus incapable ..
Month: Current Affairs - April, 2021
Category: India Nation & States Current Affairs
Topics: Bharat Biotech • COVAXIN • COVID-19 vaccine • Covishield • ICMR • Moderna • Pfizer • WHO
India approved two COVID-19 vaccines for Emergency Use
The Drug Controller General of India recently announced that it has authorised two COVID-19 vaccines for restricted Emergency Use in India. What are the two COVID-19 Vaccines approved by DGCI for emergency use? COVAXIN and COVISHIELD What is COVAXIN? The COVAXIN is the COVID-19 vaccine developed by Bharat Biotech and ICMR (Indian council of Medical ..
Month: Current Affairs - January, 2021
Category: Science & Technology Current Affairs
Topics: Bharat Biotech • COVAXIN • Covishield • DGCI • Emergency Use Authorisation • HGCO19 • ICMR • SPUTNIK V • ZyCov-D
COVAXIN of Bharat Biotech enters Phase III trials: Largest COVID-19 clinical trial of India
On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to be held in partnership with the Indian Council of Medical Research. The trials are the largest clinical trials that is conducted for COVID-19 vaccine in the country. ..
Month: Current Affairs - November, 2020
Category: India Nation & States Current Affairs
Topics: Bharat Biotech • COVAXIN • COVAXIN Vaccine • ICMR • Moderna • National Institute of Virology • Pfizer • SPUTNIK V
India-Bangladesh sign MoU on COVID-19 Vaccine
On November 5, 2020, the Government of Bangladesh signed a Memorandum of Understanding with the Serum Institute of India for priority delivery of 3 crore COVID-19 vaccine doses. This COVISHIELD Vaccines was developed by AstraZeneca and University of Oxford. Highlights According to the agreement, initially 1.5 crore people will be vaccinated as each person requires ..
Month: Current Affairs - November, 2020
Category: International Current Affairs
Topics: Bharat Biotech • COVAX • COVAXIN • COVID-19 vaccine • Covishield • eVIN • GAVI • ICMR • India-Bangladesh • Serum Institute of India